National MS Education and Awareness Month is celebrated each year in the US in March, after having been launched in 2003 by ...

Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, announced today ...

MS patients on anti-CD20 therapies are significantly less likely to discontinue treatment than those given other DMTs, a ...

In the three months since her relapsing-remitting MS diagnosis, Yara Essam has been working to prioritize her mental and ...

Machine learning is driving efforts to classify MS into distinct subtypes that may predict disease course, but two experts debate whether this will advance patient care.